0001179110-18-010987.txt : 20180829
0001179110-18-010987.hdr.sgml : 20180829
20180829145110
ACCESSION NUMBER: 0001179110-18-010987
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180828
FILED AS OF DATE: 20180829
DATE AS OF CHANGE: 20180829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Taylor Beth
CENTRAL INDEX KEY: 0001522046
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35050
FILM NUMBER: 181044067
MAIL ADDRESS:
STREET 1: 3000 KENT AVENUE
STREET 2: SUITE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENDOCYTE INC
CENTRAL INDEX KEY: 0001235007
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 KENT AVE STE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
BUSINESS PHONE: 7654637175
MAIL ADDRESS:
STREET 1: 3000 KENT AVE STE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
4
1
edgar.xml
FORM 4 -
X0306
4
2018-08-28
0
0001235007
ENDOCYTE INC
ECYT
0001522046
Taylor Beth
3000 KENT AVE, STE A1-100
WEST LAFAYETTE
IN
47906
0
1
0
0
VP Finance & Chief Acctg Offcr
Common Stock
2018-08-28
4
S
0
7892
20.0000
D
63363
D
Represents the sale of 7,892 shares in a single transaction, at a price per share of $20.0000. The shares were sold by Merrill Lynch pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
/s/ Beth A. Taylor
2018-08-29